ANXA2 and breast cancer: Moreover, Anxa2 confers increased invasiveness in breast cancer (Additional file 2: Figure S5 B and C) [18, 56, 57]; Anxa2 knockdown also inhibits migration and invasion in nasopharyngeal carcinoma [21, 22].